IDEXX Laboratories (IDXX) Revenue — Quarter Ended Jun 30, 2024
Revenue for the quarter increased compared to the immediately preceding quarter and also rose compared to the same quarter one year earlier. The sequential growth followed a pattern of consistent quarterly revenue increases.
Key takeaway
Quarter ended Jun 30, 2024 · FY2024 Q2
Revenue for the quarter increased compared to the immediately preceding quarter and also rose compared to the same quarter one year earlier. The sequential growth followed a pattern of consistent quarterly revenue increases.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1B
Revenue reported for this quarter.
Quarter-over-quarter
+4.1%
Change from the immediately preceding quarter.
Year-over-year
+6.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $915.5M | +8.8% |
| Dec 31, 2023 | $901.6M | +8.8% |
| Mar 31, 2024 | $964.1M | +7.1% |
| Jun 30, 2024 | $1B | +6.4% |
Revenue performance
The reported revenue direction was upward, continuing the positive trajectory seen in recent quarters. The company's top line expanded relative to both the prior quarter and the year-ago period.
Quarterly comparison
Compared with the immediately preceding quarter, revenue improved. Versus the same quarter one year earlier, revenue also improved, though the year-over-year growth rate has moderated from previous periods.
What to watch
The deceleration in year-over-year revenue growth warrants monitoring, as it may signal evolving demand or competitive dynamics.